Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study

المؤلفون المشاركون

Alzoubi, Karem H.
AlRyalat, Saif Aldeen
Alhawari, Hussein H.
Alshelleh, Sameeha
Alhawari, Hussam H.
Alawwa, Izzat Ahmad
Mesmar, Ahmad
Ojjoh, Khaled

المصدر

BioMed Research International

العدد

المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-7، 7ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2020-05-05

دولة النشر

مصر

عدد الصفحات

7

التخصصات الرئيسية

الطب البشري

الملخص EN

Introduction.

Approximately 15 to 33% of all dialysis treatments are complicated by intradialytic hypotension (IDH).

In this study, we tested the hypothesis that the intravenous administration of hydrocortisone prior to HD treatment could prevent IDH or at least decrease the drop in the blood pressure resulting from IDH.

Methods.

This study was approved by our local ethics committee/IRB (2017/87) and by the Jordan Food and Drug Administration (7/clinical/18).

Additionally, it is registered on ClinicalTrials.gov (NCT03465007).

In this preliminary investigational study, we screened all chronic hemodialysis patients at our clinic who were 18 years of age or older (n=82) for IDH.

There were 14 patients included in the interventional part of this study; patients were given IV hydrocortisone for 3 consecutive HD sessions, followed or preceded by 3 intervention-free sessions where they were given 5 ml of saline as a placebo.

Results.

The initial total sample size was 82 patients.

The frequency of IDH at our clinic was 24.4%.

Fourteen out of the 20 patients who were diagnosed with IDH agreed to enroll in the interventional part of our study.

The mean age of the patients in the interventional part of our study was 53.5 years (±10.3).

These patients included 5 (35.7%) men and 9 (64.3%) women.

Upon comparing the number of hypotensive attacks with and without the hydrocortisone administration, we found a significant difference (p=0.003) between the hydrocortisone and placebo treatments in which 12 (85.7%) patients had fewer IDH episodes with the hydrocortisone treatment than with placebo.

Conclusion.

This preliminary investigational study found that the administration of a stress dose of hydrocortisone prior to hemodialysis could be an effective measure for preventing or minimizing the risk of IDH episodes.

Additional prospective studies on this subject are needed.

Ruling out adrenal insufficiency in patients diagnosed with IDH is also crucial.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Alhawari, Hussein H.& Alshelleh, Sameeha& Alhawari, Hussam H.& Alawwa, Izzat Ahmad& AlRyalat, Saif Aldeen& Mesmar, Ahmad…[et al.]. 2020. Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study. BioMed Research International،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1134362

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Alhawari, Hussein H.…[et al.]. Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study. BioMed Research International No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1134362

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Alhawari, Hussein H.& Alshelleh, Sameeha& Alhawari, Hussam H.& Alawwa, Izzat Ahmad& AlRyalat, Saif Aldeen& Mesmar, Ahmad…[et al.]. Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1134362

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1134362